Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roger J Pomerantz

Showing results (61-70 of 85) with videos related to

Pageof 9
Sort By:
Biochemistry|August 27, 2003
Structural and functional study of the apelin-13 peptide, an endogenous ligand of the HIV-1 coreceptor, APJXuejun Fan, Naiming Zhou, Xiaoling Zhang, et al.
Journal of Virology|November 17, 2006
Cholesterol-depleting statin drugs protect postmitotically differentiated human neurons against ethanol- and human immunodeficiency virus type 1-induced oxidative stress in vitroEdward Acheampong, Zahida Parveen, Aschalew Mengistu, et al.
Virology|November 30, 2004
The perlecan heparan sulfate proteoglycan mediates cellular uptake of HIV-1 Tat through a pathway responsible for biological activityElias G Argyris, Joseph Kulkosky, Marie E Meyer, et al.
Journal of Virology|January 15, 2003
In a subset of subjects on highly active antiretroviral therapy, human immunodeficiency virus type 1 RNA in plasma decays from 50 to <5 copies per milliliter, with a half-life of 6 monthsMichele Di Mascio, Geethanjali Dornadula, Hui Zhang, et al.
Virology|March 7, 2002
Live and killed rhabdovirus-based vectors as potential hepatitis C vaccinesCatherine A Siler, James P McGettigan, Bernhard Dietzschold, et al.
Journal of Virology|December 13, 2002
Second-generation rabies virus-based vaccine vectors expressing human immunodeficiency virus type 1 gag have greatly reduced pathogenicity but are highly immunogenicJames P McGettigan, Roger J Pomerantz, Catherine A Siler, et al.
Virology|March 8, 2005
Ethanol potentiates HIV-1 gp120-induced apoptosis in human neurons via both the death receptor and NMDA receptor pathwaysWei Chen, Zhonghua Tang, Paolo Fortina, et al.
Journal of Neurovirology|September 16, 2005
Exogenous IL-7 induces Fas-mediated human neuronal apoptosis: potential effects during human immunodeficiency virus type 1 infectionGiuseppe Nunnari, Yan Xu, Edward A Acheampong, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 1, 2005
Current status of gene therapy strategies to treat HIV/AIDSDavid S Strayer, Ramesh Akkina, Bruce A Bunnell, et al.
The Journal of Biological Chemistry|December 14, 2002
Potent suppression of viral infectivity by the peptides that inhibit multimerization of human immunodeficiency virus type 1 (HIV-1) Vif proteinsBin Yang, Ling Gao, Lin Li, et al.
Pageof 9

Showing results (61-70 of 85) with videos related to

Sort By:
Pageof 9
Biochemistry|August 27, 2003
Structural and functional study of the apelin-13 peptide, an endogenous ligand of the HIV-1 coreceptor, APJXuejun Fan, Naiming Zhou, Xiaoling Zhang, et al.
Journal of Virology|November 17, 2006
Cholesterol-depleting statin drugs protect postmitotically differentiated human neurons against ethanol- and human immunodeficiency virus type 1-induced oxidative stress in vitroEdward Acheampong, Zahida Parveen, Aschalew Mengistu, et al.
Virology|November 30, 2004
The perlecan heparan sulfate proteoglycan mediates cellular uptake of HIV-1 Tat through a pathway responsible for biological activityElias G Argyris, Joseph Kulkosky, Marie E Meyer, et al.
Journal of Virology|January 15, 2003
In a subset of subjects on highly active antiretroviral therapy, human immunodeficiency virus type 1 RNA in plasma decays from 50 to <5 copies per milliliter, with a half-life of 6 monthsMichele Di Mascio, Geethanjali Dornadula, Hui Zhang, et al.
Virology|March 7, 2002
Live and killed rhabdovirus-based vectors as potential hepatitis C vaccinesCatherine A Siler, James P McGettigan, Bernhard Dietzschold, et al.
Journal of Virology|December 13, 2002
Second-generation rabies virus-based vaccine vectors expressing human immunodeficiency virus type 1 gag have greatly reduced pathogenicity but are highly immunogenicJames P McGettigan, Roger J Pomerantz, Catherine A Siler, et al.
Virology|March 8, 2005
Ethanol potentiates HIV-1 gp120-induced apoptosis in human neurons via both the death receptor and NMDA receptor pathwaysWei Chen, Zhonghua Tang, Paolo Fortina, et al.
Journal of Neurovirology|September 16, 2005
Exogenous IL-7 induces Fas-mediated human neuronal apoptosis: potential effects during human immunodeficiency virus type 1 infectionGiuseppe Nunnari, Yan Xu, Edward A Acheampong, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 1, 2005
Current status of gene therapy strategies to treat HIV/AIDSDavid S Strayer, Ramesh Akkina, Bruce A Bunnell, et al.
The Journal of Biological Chemistry|December 14, 2002
Potent suppression of viral infectivity by the peptides that inhibit multimerization of human immunodeficiency virus type 1 (HIV-1) Vif proteinsBin Yang, Ling Gao, Lin Li, et al.
Pageof 9